coronaviru
diseas
viral
respiratori
ill
caus
sever
acut
respiratori
syndrom
coronaviru
singlestrand
rna
viru
like
origin
bat
viru
thought
spread
mainli
persontoperson
via
close
contact
viru
transfer
hand
eye
nose
mouth
respiratori
droplet
produc
infect
person
cough
sneez
evid
vertic
transmiss
transmiss
via
breastfeed
transmiss
asymptomat
mildli
symptomat
carrier
incub
period
estim
day
mean
day
also
occur
patient
develop
symptom
day
exposur
gave
rise
establish
quarantin
period
day
exposur
clinic
spectrum
rang
asymptomat
sever
acut
respiratori
distress
figur
accord
case
seri
pediatr
patient
regist
china
center
diseas
control
prevent
cdc
databas
case
confirm
use
laboratori
test
patient
asymptomat
patient
present
mild
symptom
patient
present
moder
symptom
patient
develop
sever
critic
diseas
younger
children
suscept
sever
critic
symptom
year
old
vs
year
old
critic
case
seven
patient
less
year
old
one
death
report
boy
accord
anoth
seri
pediatr
case
day
year
old
median
year
admit
hospit
wuhan
china
patient
test
posit
asymptomat
upper
airway
symptom
pneumonia
seventyon
pediatr
patient
present
fever
last
day
median
day
three
patient
admit
intens
care
unit
comorbid
hydronephrosi
leukemia
chemotherapi
intussuscept
patient
present
intussuscept
month
old
patient
condit
deterior
lead
multipl
organ
dysfunct
death
variou
cutan
rash
recent
observ
pediatr
case
variabl
clinic
present
white
blood
cell
count
normal
reduc
seri
pediatr
case
report
leukopenia
patient
develop
lymphocytopenia
creactiv
protein
level
normal
elev
sever
critic
case
may
accompani
elev
hepat
muscular
enzym
level
high
ddimer
level
initi
phase
ill
chest
radiographi
find
show
sign
pneumonia
small
irregular
lung
opac
interstiti
alter
usual
affect
peripher
area
ground
glass
opac
ggo
consolid
may
observ
sever
case
pleural
effus
uncommon
chest
comput
tomographi
also
exhibit
ggo
segment
consolid
lung
children
present
sever
infect
may
show
lobar
consolid
bilater
lung
ultrasonographi
us
exhibit
singl
group
usual
bilater
pneumogenictyp
vertic
artifact
andor
small
area
white
lung
advanc
pneumonia
character
evid
consolid
particularli
posterobas
region
widespread
patch
artifactu
chang
similar
acut
respiratori
distress
syndrom
ard
thorac
electr
imped
tomographi
use
monitor
distribut
region
ventil
patient
ard
identifi
refractori
hypoxemia
requir
alveolar
recruit
maneuv
detect
nucleic
acid
use
realtim
revers
transcriptasepolymeras
chain
reaction
rtpcr
refer
standard
diagnosi
viru
detect
upper
airway
inferior
airway
secret
nasopharynx
swab
tracheal
aspir
intub
sputum
bronchoalveolar
lavag
blood
urin
stool
case
seri
pediatr
patient
shanghai
viral
rna
detect
nasopharynx
patient
begin
symptom
day
mean
day
first
day
ill
five
patient
rna
detect
stool
day
initi
symptom
accord
ss
resolut
paulo
state
health
secretari
rtpcr
perform
patient
sever
critic
condit
sentinel
unit
health
care
profession
symptom
typic
test
perform
asymptomat
individu
diagnosi
made
consid
clinic
find
epidemiolog
laboratori
test
confirm
infect
figur
show
flowchart
patient
flulik
symptom
propos
paulo
state
health
secretari
viral
respiratori
ill
respiratori
syncyti
viru
influenza
parainfluenza
adenoviru
metapneumoviru
frequent
caus
lower
airway
infect
children
similar
clinic
present
diagnosi
made
identifi
etiolog
agent
respiratori
secret
use
polymeras
chain
reaction
bacteri
pneumonia
main
clinic
manifest
bacteri
pneumonia
high
fever
toxem
state
atyp
pneumonia
mycoplasma
pneumonia
chlamydia
pneumonia
import
caus
agent
communityacquir
pneumonia
children
serolog
test
use
confirm
diagnosi
four
main
principl
adequ
therapeut
manag
earli
identif
earli
isol
earli
diagnosi
earli
treatment
deal
case
suspect
patient
kept
singl
room
precaut
prevent
control
infect
laboratori
confirm
mild
case
treat
symptomat
relief
medic
prefer
paracetamol
dipyron
control
fever
antivir
agent
includ
oseltamivir
ribavirin
ganciclovir
remdesivir
lopinavir
ritonavir
use
reduc
viral
load
prevent
potenti
respiratori
complic
appar
benefit
thu
far
chines
studi
patient
report
chloroquin
secur
effect
treat
pneumonia
inhibit
exacerb
pneumonia
reduc
radiograph
alter
promot
viru
elimin
decreas
period
time
diseas
anoth
french
studi
enrol
patient
show
treatment
hydroxychloroquin
associ
cure
viral
infect
util
azithromycin
lead
increas
benefit
current
studi
analyz
drug
effici
critic
ill
patient
higher
risk
death
consid
use
hydroxychloroquinechloroquin
mgkgday
basic
chloroquin
day
azithromycin
mgkg
first
day
follow
mgkgday
day
maximum
dose
mgkg
mg
sever
case
respiratori
distress
andor
hypoxia
sao
sever
acut
respiratori
syndrom
admit
hospit
indic
icu
admiss
respiratori
failur
requir
mechan
ventil
shock
organ
dysfunct
requir
treatment
main
characterist
critic
case
occurr
ard
hypoxem
acut
respiratori
distress
bilater
pulmonari
infiltr
explain
cardiac
dysfunct
fluid
overload
main
treatment
principl
ard
follow
earli
tracheal
intubationrapid
sequenc
intub
best
practic
situat
preoxygen
perform
use
flexibl
nasal
cannula
flow
lmin
reservoir
mask
lower
flux
maintain
sao
posit
pressur
ventil
bagvalvemask
similar
apparatu
avoid
gener
aerosol
sedat
perform
use
fentanyl
mg
kg
ketamin
mgkg
contraind
pulmonari
hypertens
neuromuscular
block
rocuronium
mgkg
prefer
video
laryngoscopi
util
avail
noninvas
ventil
niv
avoid
high
risk
aerosol
dispers
contamin
among
health
practition
protect
mechan
ventil
use
pressur
control
volum
cycl
low
tidal
volum
around
mlkg
plateau
pressur
cmh
posit
endexpiratori
pressur
peep
titrat
fio
reduc
pao
mmhg
sao
gener
recommend
start
peep
cmh
increas
progress
cmh
necessari
import
maintain
drive
pressur
plateau
pressur
peep
cmh
toler
hypercapnia
ph
permiss
hypercapnia
except
patient
pulmonari
hypertens
prone
posit
especi
pao
fio
mmhg
patient
maintain
posit
least
hour
per
day
oximetri
capnographi
monitor
close
tracheal
aspir
system
use
treatment
nitric
oxid
andor
sildenafil
mg
kgdose
hour
maximum
mgdose
hour
patient
persist
hypoxemia
venoven
extracorpor
membran
oxygen
ecmo
use
patient
pao
fio
mmhg
convent
treatment
protect
mechan
ventil
prone
posit
nitric
oxidesildenafil
success
accord
avail
hospit
conserv
fluid
therapi
includ
volum
restrict
patient
hemodynam
stabil
start
normal
recommend
base
hollidaysegar
rule
adjust
accord
fluid
balanc
hemodynam
clinic
condit
patient
wheez
lower
airway
obstruct
treat
aim
reduc
respiratori
droplet
dispers
insid
environ
aerosol
bronchodil
avoid
spray
dosimetr
inhal
use
possibl
util
niv
case
use
mechan
ventil
doubl
circuit
filter
part
warm
humidifi
inspiratori
circuit
higheffici
particl
separ
expiratori
circuit
necessari
emphas
niv
support
use
isol
hospit
room
neg
pressur
hour
noninvas
mechan
ventil
without
adequ
evolut
tracheal
intub
recommend
mechan
ventil
support
avoid
pulmonari
hyperinsuffl
autopeep
barotrauma
pressurecontrol
ventil
prefer
synchron
intermitt
mandatori
ventil
support
pressur
low
breath
rate
inspirationexpir
time
rate
cmh
antibiot
use
patient
secondari
bacteri
infect
basi
cultur
antibiogram
result
corticosteroid
suppress
lung
inflamm
also
inhibit
immun
respons
pathogen
clearanc
avoid
except
specif
indic
eg
bronchospasm
case
septic
shock
report
intraven
immunoglobulin
treatment
critic
ill
child
effect
patient
cardiocirculatori
dysfunct
shock
treat
fluid
therapi
vasoactiveinotrop
drug
milrinon
mgkgmin
dobutamin
mgkgmin
use
patient
low
cardiac
index
consequ
pulmonari
hypertens
normal
arteri
pressur
epinephrin
inotrop
dose
mgkgmin
use
patient
hypotens
children
adolesc
organ
dysfunct
continu
renal
replac
therapi
may
necessari
renal
dysfunct
indic
poor
prognosi
microthrombosi
associ
ischem
event
common
eg
stroke
mainli
adolesc
adult
ddimer
level
monitor
frequent
appropri
medic
transport
patient
parentcaregiv
hospit
provid
medic
transport
team
commun
pediatrician
advis
parent
wait
servic
seek
secondari
care
exampl
go
hospit
via
car
public
transport
